Skip to main content
Qinghai Spring Medicinal Resources Technology Co., Ltd logo

Qinghai Spring Medicinal Resources Technology Co., Ltd — Investor Relations & Filings

Ticker · 600381 ISIN · CNE0000017W0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 2,008 across all filing types
Latest filing 2026-05-19 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600381

About Qinghai Spring Medicinal Resources Technology Co., Ltd

https://www.verygrass.com/

Qinghai Spring Medicinal Resources Technology Co., Ltd. specializes in the research, development, and commercialization of premium health products and innovative alcoholic beverages. The company focuses on the modernization of traditional medicinal resources through scientific processing and brand positioning. Its primary product portfolio includes the "Tinghua" series of high-end baijiu, which incorporates proprietary production technologies designed to refine the flavor profile and physiological impact of traditional spirits. The firm also has a history of developing advanced Cordyceps sinensis products under the "Very Grass" brand, utilizing specialized purification and dosage forms. By integrating traditional resource utilization with modern biotechnology, the company targets high-end market segments, emphasizing quality control, scientific validation, and the creation of unique consumer experiences in the wellness and luxury goods sectors.

Recent filings

Filing Released Lang Actions
青海春天关于收到上海证券交易所《关于公司2025年年报有关事项的问询函》的公告
Regulatory Filings Classification · 85% confidence The document is an announcement that the company received an inquiry letter from the Shanghai Stock Exchange regarding its 2025 annual report and outlines requested disclosures. It does not contain the annual report itself, nor is it a certification letter or a simple publication notice; instead it is a regulatory compliance communication. This fits the fallback “Regulatory Filings” category.
2026-05-19 Chinese
青海春天2025年年度报告全文（修订版）
Annual Report Classification · 98% confidence The document is the full 2025年度报告 (Annual Report) of Qinghai Spring Medicinal Resources Technology Co., Ltd., containing audited financial statements, management discussion and analysis, corporate governance disclosures, financial tables, risk disclosures, and audit opinion. It is a comprehensive yearly report covering the company’s full financial performance and operations, not merely an announcement or supplement. Therefore, it fits the definition of an Annual Report (Code: 10-K). FY 2025
2026-05-15 Chinese
青海春天关于会计师事务所2025年度履职情况评估报告
Audit Report / Information Classification · 95% confidence The document is titled as an evaluation report on the performance of the accounting firm (audit firm) for the year 2025. It details the audit firm's qualifications, independence, audit work performed, and the company's assessment of the audit firm's performance. It references the audit of the company's 2025 financial statements and internal controls, and the issuance of an unqualified audit report. The document is not the audit report itself but an evaluation of the audit firm's performance in conducting the audit. This fits the definition of an Audit Report / Information (AR), which includes standalone audit reports and related information about audit performance and applied accounting principles. The document is 2837 characters long, which is relatively short but contains substantive audit-related content, not just an announcement or certification. Therefore, the appropriate classification is AR with high confidence.
2026-04-29 Chinese
青海春天2025年内部控制评价报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Evaluation Report" for the year 2025 by 青海春天药用资源科技股份有限公司. It discusses the evaluation of the company's internal control effectiveness as of December 31, 2025, including financial and non-financial internal control defects, their identification, and remediation status. The document contains detailed internal control assessment results, standards, and management statements about internal control effectiveness and future plans. It is not a full annual report (10-K), nor an earnings release or call transcript. It is not a simple announcement or certification but a comprehensive report on internal control evaluation. This fits the definition of an Audit Report / Information (AR), which includes audit reports and internal control evaluations separate from full annual reports.
2026-04-29 Chinese
青海春天审计委员会对会计师事务所2025年度履行监督职责情况报告
Audit Report / Information Classification · 95% confidence The document is a detailed report from the Board Audit Committee regarding the performance and supervision of the external accounting firm (政旦志远) for the fiscal year 2025. It discusses the auditor's qualifications, independence, audit scope, procedures, and the committee's evaluation of the auditor's work on the company's 2025 annual financial statements and internal control audit. The document includes references to the audit report, internal control audit, and the auditor's opinion on the 2025 financial statements. It is not the audit report itself but a supervisory report by the audit committee on the auditor's performance and compliance with regulations. This fits the definition of an Audit Report / Information (AR) filing, which includes standalone audit reports and results of internal or regulatory stress tests, excluding full annual reports. The document length is 3111 characters, which is relatively short but contains substantive content about audit supervision rather than just an announcement or certification. Therefore, the classification is AR with high confidence.
2026-04-29 Chinese
青海春天控股股东及其他关联方资金占用情况的专项说明
Audit Report / Information Classification · 95% confidence The document is a specialized audit-related report titled '控股股东及其他关联方资金占用情况的专项说明' (Special Explanation on the Use of Funds by Controlling Shareholders and Other Related Parties) for the fiscal year ending December 31, 2025. It is issued by a certified public accounting firm (政旦志远（深圳）会计师事务所) and references compliance with regulatory guidelines from the China Securities Regulatory Commission and the Shanghai Stock Exchange. The document includes detailed tables of non-operating fund occupation and related party transactions, and it explicitly states it is a special explanation report related to the audited financial statements but is not the full annual report or audit report itself. It is a standalone audit-related disclosure focusing on a specific regulatory requirement about related party fund usage, which fits the category of Audit Report / Information (AR). The document length (6064 characters) and content indicate it is not a mere announcement or certification but a substantive audit-related report. Therefore, the appropriate classification is AR with high confidence.
2026-04-29 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.